Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968328 · ClinicalTrials.gov registry record
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 315
- Enrollment target
NCT03968328: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT03968328 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 315 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03968328 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 315 participants
- Enrollment target
Study Summary
This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause specific death, intensive care unit admission, hospital length of stay, and positive blood cultures.
Interventions
- OTHER Survey Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2015-06-19 |
| Est. Completion | 2023-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03968328
The ClinicalTrials.gov registry entry for NCT03968328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT03968328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03968328 about?
NCT03968328 is a clinical study titled "Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients". This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause s...
What is the current status of trial NCT03968328?
This trial is currently completed. The enrollment target is 315 participants. The study started on 2015-06-19. Estimated completion is 2023-01-17.
What interventions are being tested in trial NCT03968328?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT03968328?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.